Shandong Weigao Group Medical Polymer Company (01066) said its profit attributable to owners for the three months ended 30 September 2014 dropped 35.8% year-on-year to Rmb223 million.
Its basic earnings per share were Rmb0.05.
The revenue was Rmb1,253 million, an increase of 1.2% from a year earlier.
For the first nine months of 2014, the net profit fell 10.4% year-on-year to Rmb696 million. The revenue grew 11.7% year-on-year to Rmb3,798 million.
The gross profit margin of the Group decreased to 58.4% from 59.3% in the same period last year, which was mainly attributable to the increase in the proportion of blood purification business to total business, slowdown in sales and price reduction of intravenous catheter needles and the rapid increase in sales of orthopaedic economy branded products.
etnet榮獲HKEX Awards 2023 「最佳表現證券數據供應商」大獎► 了解詳情
